OP011 Tralokinumab (CAT-354), an interleukin 13 antibody,...

Journal of Crohn's and Colitis 2014 / 02 Vol. 8

OP011 Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe ulcerative colitis: A phase 2 randomized placebo-controlled study

Danese, S., Rudzinski, J., Brandt, W., Dupas, J.L., Peyrin-Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukas, M., Knutsson, M., Erlandsson, F., Hansen, M. Berner, Keshav, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1016/S1873-9946(14)60012-X
Date:
February, 2014
File:
PDF, 68 KB
english, 2014
Conversion to is in progress
Conversion to is failed